AmerisourceBergen in the news

AmerisourceBergen made 14 acquisitions across 4 countries and 8 sectors, with the most recent being PharmaLex in September 2022.

AmerisourceBergen faces a revived False Claims Act whistleblower claim concerning alleged unlawful medication overpayments to Medicare and federal agencies.

Cencora delivered strong Q3 FY2026 financial results driven by its specialty pharmaceutical platform and strategic investments, leading to raised fiscal year EPS guidance and significant share repurchases.

AmerisourceBergen has made 14 acquisitions, with the most recent being PharmaLex in September 2022, and peak activity in 2018.

AmerisourceBergen's Steve Collis discusses vaccine timelines and diversity goals, while Barnes & Noble's CEO James Daunt revitalizes the company, making it cool again.

Cencora, formerly known as AmerisourceBergen, is transitioning its core pharmaceutical distribution business toward high-margin specialty logistics and manufacturer consulting services.

AmerisourceBergen and TPG are partnering to purchase the oncology practice network OneOncology for $2.1 billion.

AmerisourceBergen announced the release date and time for its fiscal second-quarter earnings, scheduled for April 25, 2013, along with details for the conference call.

AmerisourceBergen Foundation and Good Neighbor Pharmacy launched a scholarship program to support Black and African American graduate students pursuing Pharmacy Doctorate Degrees, aiming to increase diversity in the pharmacy profession.

The healthcare logistics market is experiencing significant growth, driven by expanding pharmaceutical distribution networks, increasing demand for cold chain solutions, and the development of digital and smart inventory systems, with key players like AmerisourceBergen.

The bio-pharmaceutical logistics market is experiencing substantial growth, fueled by personalized medicine, cold chain solutions, and digital innovations, with key players like AmerisourceBergen solidifying their market positions.

A market report forecasts significant growth in healthcare logistics through 2030, driven by pharmaceutical distribution demands and cold chain technology advancements.

AmerisourceBergen won a court ruling to keep its disputed tax amounts confidential during a legal battle with Pennsylvania officials.

AmerisourceBergen can redact tax information in a Pennsylvania court case regarding its tax obligations, according to a state court ruling.

Cencora, formerly AmerisourceBergen, is acquiring a majority stake in OneOncology for $5 billion to expand its pharmaceutical distribution and services within the oncology market.

Cencora is acquiring a majority stake in OneOncology for $5 billion, valuing the company at $7.4 billion and furthering its pharmaceutical-centric strategy.

Cencora invests $80 million to expand its Dothan distribution center, significantly increasing storage for specialty medications as part of a $1 billion national network enhancement.

Cencora is investing $1 billion over five years to expand its U.S. pharmaceutical distribution network, including new automated distribution centers in Ohio and California, and increased cold chain capacity in Alabama.

Cencora is investing $1 billion over five years to expand its U.S. drug distribution and cold chain logistics, including new highly automated facilities in Ohio and California, to strengthen its pharmaceutical supply chain.

A federal appeals court reinstated a $2.5 billion lawsuit against McKesson, Cardinal Health, and AmerisourceBergen, alleging their role in fueling the opioid crisis in West Virginia.